Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Sun Pharma Says Philogen Resubmits Marketing Authorization Application To EMA For Nidlegy In Melanoma

BRIEF-Sun Pharma Says Philogen Resubmits Marketing Authorization Application To EMA For Nidlegy In Melanoma

- Sun Pharmaceutical Industries Ltd SUN.NS:

  • SUN PHARMA - PHILOGEN RESUBMITS MARKETING AUTHORIZATION APPLICATION TO EMA FOR NIDLEGY IN MELANOMA

  • SUN PHARMA - NIDLEGY MARKETING AUTHORIZATION APPLICATION RESUBMITTED TO EMA

Source text: ID:nBSE7mx7cX

Further company coverage: SUN.NS


((reuters.briefs@thomsonreuters.com;))

Recent news on Sun Pharmaceutical Industries

See all news